Showing results (1331-1340 of 1,689) with videos related to

Sort By:
Pageof 169
Nanoimpact|June 7, 2024
The toxicity of superparamagnetic iron oxide nanoparticles induced on the testicular cells: In vitro studyGraziela de P F Dantas, Fausto S Ferraz, John L P Coimbra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trialT E Witzig, K Tobinai, L Rigacci, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 23, 2020
Validation of a Core Patient-Reported Outcome Measure for Fatigue in Patients Receiving Hemodialysis: The SONG-HD Fatigue InstrumentAngela Ju, Armando Teixeira-Pinto, Allison Tong, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple MyelomaLuciano J Costa, Yi Lin, R Frank Cornell, et al.
British Journal of Anaesthesia|August 11, 2023
An anchor-tether 'hindered' HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain modelGareth R Tibbs, Rajendra Uprety, J David Warren, et al.
Reproductive Toxicology (Elmsford, N.Y.)|April 1, 2024
Effects of superparamagnetic iron oxide nanoparticles (SPIONS) testicular injection on Leydig cell function and sperm production in a murine modelFausto S Ferraz, Graziela de P F Dantas, John L P Coimbra, et al.
ACS ES&T Air|August 21, 2024
Primary Sulfate Is the Dominant Source of Particulate Sulfate during Winter in Fairbanks, AlaskaAllison Moon, Ursula Jongebloed, Kayane K Dingilian, et al.
Current Medical Research and Opinion|July 11, 2022
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myelomaLuciano J Costa, Parameswaran Hari, Jesus G Berdeja, et al.
Pageof 169